CD40 and melanoma: Thus, preventing the reprogramming of macrophages induced by inhibition of CD40/IL-27 signals shows potential as a precise immunotherapeutic strategy in melanoma (79).As specific components of myeloid origin, platelets can also affect macrophage polarization.